Vaccinations are a crucial intervention in combating infectious diseases. The three neurotropic Alphaviruses, Eastern (EEEV), Venezuelan (VEEV), and Western (WEEV) equine encephalitis viruses, are pathogens of interest for animal health, public health, and biological defense. In both equines and humans, these viruses can cause febrile illness that may progress to encephalitis. Currently, there are no licensed treatments or vaccines available for these viruses in humans. Experimental vaccines have shown variable efficacy and may cause severe adverse effects. Here, we outline recent strategies used to generate vaccines against EEEV, VEEV, and WEEV with an emphasis on virus-vectored and plasmid DNA delivery. Despite candidate vaccines protecting against one of the three viruses, few studies have demonstrated an effective trivalent vaccine. We evaluated the potential of published vaccines to generate cross-reactive protective responses by comparing DNA vaccine sequences to a set of EEEV, VEEV, and WEEV genomes and determining the vaccine coverages of potential epitopes. Finally, we discuss future directions in the development of vaccines to combat EEEV, VEEV, and WEEV.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350001 | PMC |
| http://dx.doi.org/10.3390/vaccines8020273 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening.
bioRxiv
August 2024
Diamond Light Source, Harwell Science & Innovation Campus, Didcot, United Kingdom.
Article Synopsis
- - Chikungunya virus (CHIKV) causes severe symptoms like fever, rash, and joint pain, with millions infected, primarily in low and middle-income regions, due to its mosquito carriers spreading into new areas.
- - The virus has a macrodomain in its genome that interferes with the immune response, making it essential for viral replication, which positions it as a potential target for antiviral drug development.
- - A high-throughput crystallographic fragment screen identified 109 fragments that bind to the CHIKV nsP3 macrodomain, leading to the design of three fragments aimed at trapping the active sites, and this data is publicly available for future research.
Displaying alphavirus physicochemical consensus antigens on immunogenic liposomes enhances antibody elicitation in mice.
Virology
September 2024
Department of Biochemistry and Molecular Biology, UTMB Galveston, 77555, USA; Institute for human infections and immunity, UTMB Galveston, 77555, USA. Electronic address:
Cobalt-porphyrin phospholipid displays recombinant protein antigens on liposome surfaces via antigen polyhistidine-tag (His-tag), and when combined with monophosphorylated lipid A and QS-21 yields the "CPQ" vaccine adjuvant system. In this proof of principle study, CPQ was used to generate vaccine prototypes that elicited antibodies for two different alphaviruses (AV). Mice were immunized with computationally designed, His-tagged, physicochemical property consensus (PCP) protein antigens representing the variable B-domain of the envelope protein 2 (E2) from the serotype specific Venezuelan Equine Encephalitis Virus (VEEV) or a broad-spectrum AV-antigen termed EVC The CPQ adjuvant enhanced the antigenicity of both proteins without eliciting detectable anti-His-tag antibodies.
View Article and Find Full Text PDFPhagocyte-expressed glycosaminoglycans promote capture of alphaviruses from the blood circulation in a host species-specific manner.
PNAS Nexus
April 2024
Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Article Synopsis
- The study explores how the levels of viremia (virus in the bloodstream) affect arbovirus transmission and disease severity, particularly focusing on the relationship between viral variants and glycosaminoglycan (GAG) interactions.
- Using an in vivo model, researchers found that GAG-binding viruses are cleared from the bloodstream faster than non-GAG-binding ones, but the rate of clearance varies by virus type and relies on phagocytes for some variants.
- The findings highlight the role of GAGs in viral clearance and suggest that different species, like birds and mice, may interact with viruses differently based on their unique GAG structures, impacting arbovirus spread and ecology.
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
Vaccine
April 2024
Bavarian Nordic GmbH, Fraunhoferstrasse 13, 82152 Martinsried, Germany. Electronic address:
Article Synopsis
- The study investigates the safety and effectiveness of a new vaccine, MVA-BN-WEV, designed to protect against three encephalitic alphaviruses (WEEV, EEEV, VEEV) in healthy adults.
- Forty-five participants were given two doses of the vaccine at varying strengths, monitored for side effects and immune response over six months.
- Results showed the vaccine was generally safe with mild side effects, and it successfully triggered strong immune responses against all three viruses, especially at higher doses.
Brilacidin as a Broad-Spectrum Inhibitor of Enveloped, Acutely Infectious Viruses.
Microorganisms
December 2023
Center for Infectious Disease Research, School of Systems Biology, George Mason University, Manassas, VA 20110, USA.
Article Synopsis
- Alphaviruses and bunyaviruses, which lack FDA-approved treatments, can cause serious illnesses like encephalitis and hemorrhagic fever, with specific viruses linked to severe health outcomes.
- Brilacidin, a small molecule designed based on natural host defenses, showed antiviral activity against several alphaviruses (like VEEV and SINV) and the bunyavirus RVFV when tested in human and monkey cells.
- The effectiveness of brilacidin depended on the timing of administration, requiring doses both before and after infection for better results, and exhibited only modest activity against a non-enveloped virus, suggesting it may be less effective in those cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!